Scientists at The Wistar Institute Discover Novel Series of SARS-CoV-2 Mpro Inhibitors for Potential New COVID-19 Treatments
October 09, 2024
October 09, 2024
PHILADELPHIA, Pennsylvania, Oct. 9 (TNSres) -- The Wistar Institute issued the following news release:
New research from The Wistar Institute's Salvino lab -- led by professor Joseph Salvino, Ph.D. -- has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that, according to preclinical testing, effectively inhibits COVID-19 and synergizes with existing anti-COVID therapies. Their new discovery is detailed in the paper, "De . . .
New research from The Wistar Institute's Salvino lab -- led by professor Joseph Salvino, Ph.D. -- has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that, according to preclinical testing, effectively inhibits COVID-19 and synergizes with existing anti-COVID therapies. Their new discovery is detailed in the paper, "De . . .